Spire Healthcare Group plc (LON:SPI)
London · Delayed Price · Currency is GBP · Price in GBX 213.00
+5.00 (2.40%)
Aug 7, 2025, 4:35 PM BST
Sage Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 18.5 | 25.4 | 27.3 | 8.6 | -9.7 | -233.9 | Upgrade |
Depreciation & Amortization | 113.1 | 109.9 | 103.2 | 97.9 | 97.1 | 94 | Upgrade |
Other Amortization | 3.8 | 3.8 | 1.9 | 4.6 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -0.4 | -5.2 | -0.3 | 0.8 | -23.5 | 0.3 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 200 | Upgrade |
Loss (Gain) From Sale of Investments | -4.2 | -5.8 | -3.6 | -3 | - | - | Upgrade |
Stock-Based Compensation | 4.3 | 4.2 | 3.7 | 2.3 | 2.8 | 1.7 | Upgrade |
Other Operating Activities | 107.2 | 110.4 | 98.8 | 85.4 | 105.7 | 101.5 | Upgrade |
Change in Accounts Receivable | -17.8 | -11 | -12.7 | -6.9 | 1.7 | -15.5 | Upgrade |
Change in Inventory | -0.5 | -2.3 | -3.7 | -0.4 | -1.9 | -5.6 | Upgrade |
Change in Accounts Payable | 13.1 | 9 | 2.2 | 8.2 | 14.3 | 18.5 | Upgrade |
Change in Other Net Operating Assets | 4.8 | -2.7 | -1.3 | -15.9 | -2.7 | -1.3 | Upgrade |
Operating Cash Flow | 241.9 | 235.7 | 215.5 | 181.6 | 183.8 | 159.7 | Upgrade |
Operating Cash Flow Growth | 4.76% | 9.37% | 18.67% | -1.20% | 15.09% | -20.82% | Upgrade |
Capital Expenditures | -109 | -109.3 | -83.9 | -87.7 | -69.3 | -46.6 | Upgrade |
Sale of Property, Plant & Equipment | 1.6 | 11.7 | 0.8 | 3.2 | 35.3 | - | Upgrade |
Cash Acquisitions | -2.8 | - | -73.2 | -11.3 | -14.7 | - | Upgrade |
Sale (Purchase) of Intangibles | -1.4 | -2.8 | -0.5 | - | - | - | Upgrade |
Investment in Securities | 0.7 | 0.7 | 0.7 | 0.5 | 0.4 | 0.2 | Upgrade |
Other Investing Activities | 0.7 | 0.7 | -1.1 | - | - | 0.1 | Upgrade |
Investing Cash Flow | -110.2 | -99 | -157.2 | -95.3 | -48.3 | -46.3 | Upgrade |
Long-Term Debt Issued | - | 5 | 60 | 325 | - | - | Upgrade |
Long-Term Debt Repaid | - | -31.2 | -47.2 | -445.2 | -14.7 | -13.4 | Upgrade |
Net Debt Issued (Repaid) | -24.3 | -26.2 | 12.8 | -120.2 | -14.7 | -13.4 | Upgrade |
Issuance of Common Stock | 0.4 | - | - | 3.1 | - | - | Upgrade |
Repurchase of Common Stock | -11.8 | -6.2 | -3.1 | - | - | - | Upgrade |
Common Dividends Paid | -9.2 | -8.5 | -2 | -0.1 | - | - | Upgrade |
Other Financing Activities | -109 | -104.2 | -90.6 | -97.5 | -24.5 | -84.5 | Upgrade |
Financing Cash Flow | -153.9 | -145.1 | -82.9 | -214.7 | -39.2 | -97.9 | Upgrade |
Net Cash Flow | -22.2 | -8.4 | -24.6 | -128.4 | 96.3 | 15.5 | Upgrade |
Free Cash Flow | 132.9 | 126.4 | 131.6 | 93.9 | 114.5 | 113.1 | Upgrade |
Free Cash Flow Growth | 5.06% | -3.95% | 40.15% | -17.99% | 1.24% | -19.84% | Upgrade |
Free Cash Flow Margin | 8.60% | 8.36% | 9.68% | 7.83% | 10.35% | 12.29% | Upgrade |
Free Cash Flow Per Share | 0.33 | 0.31 | 0.32 | 0.23 | 0.29 | 0.28 | Upgrade |
Cash Interest Paid | 101.9 | 98.1 | 90 | 94.6 | 80 | 84.5 | Upgrade |
Cash Income Tax Paid | 0.1 | 0.1 | 0.1 | 0.1 | - | -3.6 | Upgrade |
Levered Free Cash Flow | 32.71 | 40.83 | 50.16 | 8.64 | 65.13 | 50.75 | Upgrade |
Unlevered Free Cash Flow | 94.65 | 100.83 | 105.85 | 57.73 | 119.5 | 103.94 | Upgrade |
Change in Net Working Capital | 6.5 | -5.9 | -3.3 | 19.2 | -38.5 | -12.6 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.